REXAHN PHARMACEUTICALS, INC. Separation Agreements
3 Contracts & Agreements
- Separation and Release Agreement by and between Ocuphire Pharma, Inc. and Mina Sooch, dated June 8, 2023 (Filed With SEC on August 11, 2023)
- Separation, Transition and General Release Agreement dated November 14, 2018 (Filed With SEC on November 16, 2018)
- Separation, Transition and General Release Agreement, dated as of December 11, 2017, by and between Rexahn Pharmaceuticals, Inc. and Tae Heum (Ted) Jeong (Filed With SEC on March 9, 2018)
